Vaxart, Inc. VXRT
0.40 USD -0.01 (-1.84%)
Nov 3, 2026, 3:59 PM EST
0.3851 Day range 0.41
0.31 52-week range 0.84
- YTD
- +14.29%
- 1 year
- +21.21%
News
globenewswire.com Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET Company to report third quarter 2026 financial results on November 5 SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company…
globenewswire.com Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model Second-generation oral mucosal vaccine candidate (VXA-H5-02) induced robust cross-neutralizing antibodies, significantly reduced viral load, and completely protected against lethal clade 2.3.4.4b…
marketbeat.com Vaxart Highlights Oral Vaccine Platform, COVID Trial Progress at H.C. Wainwright Conference Vaxart OTCMKTS: VXRT Chief Executive Officer Steve Lo outlined the company's oral vaccine platform, its government-funded COVID-19 study and development opportunities in norovirus and influenza…
globenewswire.com Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
globenewswire.com Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology European Patent Office granted Vaxart a new patent, extending intellectual property protection for Vaxart's Norovirus vaccine program through at least 2036 across key European markets European Patent…
marketbeat.com Vaxart Q2 Earnings Call Highlights Vaxart OTCMKTS: VXRT said it has reported positive 12-month safety data from the 400-participant Sentinel cohort of its Phase II-B COVID-19 vaccine trial and remains on track to disclose top-line…
seekingalpha.com Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript
globenewswire.com Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET Company to report second quarter 2026 financial results on August 6 SOUTH SAN FRANCISCO, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company…
defenseworld.net Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now Vaxart (OTCMKTS:VXRT) held its 2026 Annual Meeting of Stockholders, where investors re-elected the company's full slate of directors, ratified its auditor and rejected the company's non-binding…
globenewswire.com Vaxart to Participate in BTIG Biotechnology Conference 2026 SOUTH SAN FRANCISCO, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
marketbeat.com Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now Vaxart OTCMKTS: VXRT held its 2026 Annual Meeting of Stockholders, where investors re-elected the company's full slate of directors, ratified its auditor and rejected the company's non-binding…
globenewswire.com Vaxart Announces Results of Annual Meeting of Stockholders SOUTH SAN FRANCISCO, Calif. , July 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing a range of oral recombinant…
globenewswire.com Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reported
globenewswire.com Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements Company to Appoint Mutually Agreed Upon Independent Director; Forms Stockholder Engagement and Clinical and Regulatory Affairs Committees
globenewswire.com Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company's Highly Qualified Director Nominees on the WHITE Proxy Card TODAY Details Strategic Actions Taken by the Board to Advance the Company's Pipeline and Drive Value Creation Vaxart's Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of…
globenewswire.com Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial Latest Modification is Important Required Step to Releasing 12-month Data from 400-participant Sentinel Cohort Funding to Advance Data Analysis from More Than 5,000 Trial Participants Ahead of Key…
globenewswire.com Vaxart's Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting Urges Stockholders to Vote “FOR” ALL Six of Vaxart's Director Nominees on the WHITE Proxy Card TODAY Visit Vote.Vaxart.com for Additional Information and Voting Resources SOUTH SAN FRANCISCO, Calif.,…
globenewswire.com Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum SOUTH SAN FRANCISCO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
globenewswire.com Vaxart to Participate in BTIG Infectious Disease Day 2026 SOUTH SAN FRANCISCO, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com Earnings Scheduled For May 13, 2025
benzinga.com Earnings Scheduled For March 20, 2025 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com Earnings Scheduled For November 13, 2024
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com Earnings Scheduled For March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
- benzinga.com Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on…
- benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
- benzinga.com Earnings Scheduled For August 3, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
- benzinga.com Crude Oil Rises Over 1%; United Natural Foods Posts Downbeat Results U.S. stocks traded mixed toward the end of trading, with Dow Jones gaining around 100 points on Wednesday. The Dow traded up 0.30% to 33,672.74 while the NASDAQ fell 1.11% to 13,129.19. The S&P 500,…
benzinga.com Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for…
benzinga.com Nasdaq Drops Over 100 Points; Campbell Soup Earnings Beat Estimates U.S. stocks traded mixed midway through trading, with Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded up 0.20% to 33,639.18 while the NASDAQ fell 0.90% to 13,156.82. The S&P…
benzinga.com Earnings Scheduled For May 4, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.- benzinga.com Stocks That Hit 52-Week Lows On Monday Monday's session saw 114 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 337 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For March 15, 2023 Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 325 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday OnFriday, 143 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 298 companies achieved new lows for the year.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday saw 219 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 167 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 107 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 79 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 184 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.